Teva Pharmaceutical Industries Ltd. and Medicis Pharmaceutical Corporation today announced they have agreed to terminate all legal disputes between them relating to SOLODYN (minocycline HCl, USP) Extended Release Tablets.
the details can be read here.
No comments:
Post a Comment